Paper Details

  1. Home
  2. Paper Details

Effects of anakinra monotherapy on joint damage in patients with rheumatoid arthritis. Extension of a 24-week randomized, placebo-controlled trial.

Author: BresnihanBarry, GenantHarry K, NewmarkRichard, RobbinsSean

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study evaluated the effects of anakinra on radiographic joint damage in patients with rheumatoid arthritis (RA). The study found that anakinra significantly slowed radiographic joint damage in patients with RA.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To determine the effects of treatment on the radiologic manifestations of joint damage in patients with rheumatoid arthritis (RA) who participated in a 24-week extension study of a randomized, placebo-controlled clinical trial of anakinra, a recombinant human interleukin 1 receptor antago...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/15170922

データ提供：米国国立医学図書館（NLM）

Anakinra: A Potential Oasis in the Desert of Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic inflammatory disease that can cause significant pain, stiffness, and joint damage. This study investigates the long-term effects of anakinra, a recombinant human interleukin 1 receptor antagonist, on joint damage in patients with RA.

Slowing Down the Desert Storm: Anakinra's Impact on Joint Damage

The study demonstrated that anakinra treatment, when continued for 48 weeks, significantly slowed down the progression of radiographic joint damage in patients with RA. This finding suggests that anakinra could play a crucial role in managing the long-term consequences of RA, potentially preserving joint function and improving quality of life.

A Light in the Desert: Hope for RA Patients

This study offers a beacon of hope for patients with RA, suggesting that anakinra can help mitigate the debilitating effects of the disease and potentially improve their long-term health outcomes. It emphasizes the importance of early diagnosis and treatment for managing RA and preventing further joint damage.

Dr. Camel's Conclusion

This study is like a camel caravan discovering a hidden oasis in the desert of rheumatoid arthritis, offering hope and potential relief from the debilitating effects of the disease. Anakinra, like a refreshing spring, can help slow the progression of joint damage and improve the quality of life for patients living with RA.

Date :
  1. Date Completed 2004-09-14
  2. Date Revised 2016-11-24
Further Info :

Pubmed ID

15170922

DOI: Digital Object Identifier

0315162X-31-1103

Related Literature

Article Analysis
・Effects of anakinra
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.